A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if SB-742457 is a safe treatment and what effects it
has on the symptoms of mild to moderate Alzheimer's disease. SB-742457 is a new treatment
which is thought to increase the levels of certain chemicals in the brain that are often
decreased in patients with Alzheimer's disease.